Skip to main content
. 2021 Feb;23(2):253–263. doi: 10.1016/j.jmoldx.2020.11.003

Figure 3.

Figure 3

Relative distribution of TERT alterations in primary compared with metastatic/recurrent tumors. TERT promoter mutations and amplifications combined, for specific tumor types, are depicted for primary compared with metastatic/recurrent tumors. ∗∗P < 5 × 10−3.